CJC-1295 (No DAC)
A short-acting version. Each shot gives you about a 30-minute GH pulse. Usually paired with Ipamorelin.
Typical dose
300 mcg
15u (2 mg/mL) / 9.0u (3.33 mg/mL), Nightly 5×/week
Cycle
8–12 weeks on / 4 weeks off
Timing
Fasted AM or fasted pre-bed
Where
Abdomen
Check your units. The units in this table assume 2 mg/mL or 3.33 mg/mL, but the guide's recommended mix makes 5 mg/mL. If you mix it that way, your units will be different. Use the calculator to get the right draw for your vial.
Standard
Weeks 1–2
10u (2 mg/mL) / 6.0u (3.33 mg/mL)200 mcg · Nightly 5×/week
Start low and assess how your body responds before increasing.
Weeks 3–12
15u (2 mg/mL) / 9.0u (3.33 mg/mL)300 mcg · Nightly 5×/week
Standard effective dose for most users.
Off
4 weeks
Off period, let your pituitary and receptors recover before the next cycle.
Dose note: GHRH receptors saturate near ~100 mcg; 300 mcg adds little extra GH, mostly cost.
Cycle & timing
Cycle: 8–12 weeks on / 4 weeks off. Max: 12 weeks on / 4–8 weeks off. 5 nights/week (M–F) preferred over daily.
Timing: Fasted AM or fasted pre-bed. No food 60–90 min before; no food 60 min after, food-driven insulin blunts the GH pulse.
Where: Abdomen. Can combine with Ipamorelin in same syringe.
What to expect
Better sleep by 1–2 wks, recovery by 4–6, body-composition change by 8–12 wks.
How much to buy
For 12-wk @ 300 mcg × 5/wk:
4
× 5mg vials
2
× 10mg vials
Men & women
Men: Men convert GH to IGF-1 more efficiently and more often overshoot the age ceiling (a higher malignancy signal), aim mid-normal for age, don’t chase the top.
Women: Women make ~3× the GH of men yet have similar IGF-1, they’re less responsive, so often need a higher dose to move IGF-1. Oral estrogen blunts IGF-1 further (read it as running low); a skin patch/gel is more predictable.